Depressive Disorders - Southern Europe

  • Southern Europe
  • Revenue in the Depressive Disorders market is projected to reach US$1.84bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 1.33%, resulting in a market volume of US$1.94bn by 2028.
  • In global comparison, most revenue will be generated in the United States (US$6,263.00m in 2024).
  • In relation to total population figures, per person revenues of US$146.70 are generated in 2024.

Key regions: India, Europe, Japan, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Depressive Disorders market in Southern Europe is experiencing steady growth due to a combination of customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Depressive Disorders market in Southern Europe are shifting towards more holistic and natural treatment options. There is a growing demand for alternative therapies such as herbal remedies, acupuncture, and mindfulness-based interventions. This shift is driven by a desire for a more personalized and integrative approach to mental health, as well as concerns about the potential side effects of traditional pharmaceutical treatments.Trends in the market indicate an increasing awareness and destigmatization of mental health issues in Southern Europe. This has led to a greater willingness among individuals to seek help for depressive disorders and a higher demand for treatment options. As a result, there has been a rise in the number of mental health clinics, specialized treatment centers, and support groups throughout the region.Local special circumstances in Southern Europe, such as high levels of unemployment and economic instability, have contributed to the growth of the Depressive Disorders market. The financial crisis and subsequent austerity measures have had a significant impact on the mental health of individuals in the region, leading to an increased prevalence of depressive disorders. This has created a greater need for accessible and affordable treatment options.Underlying macroeconomic factors, such as government healthcare policies and funding, also play a role in the development of the Depressive Disorders market in Southern Europe. Governments in the region have recognized the importance of mental health and have implemented policies to improve access to treatment and support services. This has resulted in increased funding for mental health programs and initiatives, leading to a growth in the market.In conclusion, the Depressive Disorders market in Southern Europe is growing due to shifting customer preferences towards holistic treatments, increasing awareness and destigmatization of mental health issues, local special circumstances such as economic instability, and supportive government policies. These factors are driving the demand for a wide range of treatment options and support services in the region.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)